These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11505972)

  • 1. Autoimmunity, self-tolerance and immune homeostasis: from whole animal phenotypes to molecular pathways.
    Goodnow CC; Glynne R; Akkaraju S; Rayner J; Mack D; Healy JI; Chaudhry S; Miosge L; Wilson L; Papathanasiou P; Loy A
    Adv Exp Med Biol; 2001; 490():33-40. PubMed ID: 11505972
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanisms of self-tolerance and autoimmunity: from whole-animal phenotypes to molecular pathways.
    Goodnow CC; Glynne R; Mack D; Weintraub B; Rathmell J; Healy JI; Chaudhry S; Miosge L; Loy A; Wilson L
    Cold Spring Harb Symp Quant Biol; 1999; 64():313-22. PubMed ID: 11232301
    [No Abstract]   [Full Text] [Related]  

  • 3. Repression of B7.2 on self-reactive B cells is essential to prevent proliferation and allow Fas-mediated deletion by CD4(+) T cells.
    Rathmell JC; Fournier S; Weintraub BC; Allison JP; Goodnow CC
    J Exp Med; 1998 Aug; 188(4):651-9. PubMed ID: 9705947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homeostasis and self-tolerance in the immune system: turning lymphocytes off.
    Van Parijs L; Abbas AK
    Science; 1998 Apr; 280(5361):243-8. PubMed ID: 9535647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inducible Fas-resistance mediated by IL-4 in activated B cells.
    Foote LC; Marshak-Rothstein A; Rothstein TL
    Ann N Y Acad Sci; 1997 Apr; 815():114-5. PubMed ID: 9186645
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of autoimmunity by inhibition of T cell costimulation.
    Daikh DI; Wofsy D
    Adv Exp Med Biol; 2001; 490():113-7. PubMed ID: 11505969
    [No Abstract]   [Full Text] [Related]  

  • 7. Fas/Fas ligand pathway, apoptosis, and clonal anergy involved in systemic acetylcholine receptor T cell epitope tolerance.
    Deng C; Goluszko E; Christadoss P
    J Immunol; 2001 Mar; 166(5):3458-67. PubMed ID: 11207304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blocking of the B7-CD28 pathway increases the capacity of FasL+ (CD95L+) dendritic cells to kill alloactivated T cells.
    Lu L; Qian S; Starzl TE; Lynch DH; Thomson AW
    Adv Exp Med Biol; 1997; 417():275-82. PubMed ID: 9286373
    [No Abstract]   [Full Text] [Related]  

  • 9. Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b.
    Bachmaier K; Krawczyk C; Kozieradzki I; Kong YY; Sasaki T; Oliveira-dos-Santos A; Mariathasan S; Bouchard D; Wakeham A; Itie A; Le J; Ohashi PS; Sarosi I; Nishina H; Lipkowitz S; Penninger JM
    Nature; 2000 Jan; 403(6766):211-6. PubMed ID: 10646608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic GVH prevents anergy in bone marrow self-reactive B cells: a selective increase in post-endoplasmic reticulum processing and trafficking to the cell surface of autoreactive IgM receptors.
    Feuerstein N; Shivers D; Chen F; Eisenberg RA; Finkel TH
    Int Immunol; 2003 Aug; 15(8):975-85. PubMed ID: 12882835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of preactivated autologous T lymphocytes on CD80, CD86 and CD95 expression by chronic lymphocytic leukemia B cells.
    Romano C; De Fanis U; Sellitto A; Dalla Mora L; Chiurazzi F; Giunta R; Rotoli B; Lucivero G
    Leuk Lymphoma; 2003 Nov; 44(11):1963-71. PubMed ID: 14738151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple paths to loss of anergy and gain of autoimmunity.
    Conrad FJ; Rice JS; Cambier JC
    Autoimmunity; 2007 Sep; 40(6):418-24. PubMed ID: 17729035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of T cell anergy in the absence of CTLA-4/B7 interaction.
    Frauwirth KA; Alegre ML; Thompson CB
    J Immunol; 2000 Mar; 164(6):2987-93. PubMed ID: 10706686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of apoptosis following antigen presentation by T cells: anergy and apoptosis are two separate phenomena.
    Hargreaves RG; Borthwick NJ; Gilardini Montani MS; Piccolella E; Carmichael P; Lechler RI; Akbar AN; Lombardi G
    Transplant Proc; 1997; 29(1-2):1102-4. PubMed ID: 9123219
    [No Abstract]   [Full Text] [Related]  

  • 15. Regulation of T and B cell responses by modulating interactions between CD28/CTLA4 and their ligands, CD80 and CD86.
    Lane P
    Ann N Y Acad Sci; 1997 Apr; 815():392-400. PubMed ID: 9186685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic cells can be used as physiological adjuvant in vivo.
    Moser M; Sornasse T; De Smedt T; Van Mechelen M; Heynderickx M; Flamand V; De Becker G; Thielemans K; Urbain J; Leo O
    Adv Exp Med Biol; 1995; 378():501-5. PubMed ID: 8526128
    [No Abstract]   [Full Text] [Related]  

  • 17. Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways.
    Fife BT; Bluestone JA
    Immunol Rev; 2008 Aug; 224():166-82. PubMed ID: 18759926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune tolerance and the nervous system.
    Anderson DE; Hafler DA
    Adv Exp Med Biol; 2001; 490():79-98. PubMed ID: 11505978
    [No Abstract]   [Full Text] [Related]  

  • 19. Antigen presentation and immune regulatory capacity of immature and mature-enriched antigen presenting (dendritic) cells derived from human bone marrow.
    Jin Y; Fuller L; Ciancio G; Burke GW; Tzakis AG; Ricordi C; Miller J; Esquenzai V
    Hum Immunol; 2004 Feb; 65(2):93-103. PubMed ID: 14969764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Murine B7-2, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin 2 production.
    Freeman GJ; Borriello F; Hodes RJ; Reiser H; Gribben JG; Ng JW; Kim J; Goldberg JM; Hathcock K; Laszlo G
    J Exp Med; 1993 Dec; 178(6):2185-92. PubMed ID: 7504059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.